137 related articles for article (PubMed ID: 11028445)
21. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid suppresses interleukin 6 production in normal human osteoblasts.
Ahmed N; Sammons J; Khokher MA; Hassan HT
Cytokine; 2000 Mar; 12(3):289-93. PubMed ID: 10704257
[TBL] [Abstract][Full Text] [Related]
23. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
Franchimont N; Durant D; Canalis E
Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
[TBL] [Abstract][Full Text] [Related]
25. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering.
Yang X; Tare RS; Partridge KA; Roach HI; Clarke NM; Howdle SM; Shakesheff KM; Oreffo RO
J Bone Miner Res; 2003 Jan; 18(1):47-57. PubMed ID: 12510805
[TBL] [Abstract][Full Text] [Related]
26. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells.
Nöth U; Osyczka AM; Tuli R; Hickok NJ; Danielson KG; Tuan RS
J Orthop Res; 2002 Sep; 20(5):1060-9. PubMed ID: 12382974
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of NF-kappaB involved in osteoblast development through interleukin-6.
Deyama Y; Takeyama S; Suzuki K; Yoshimura Y; Nishikata M; Matsumoto A
Biochem Biophys Res Commun; 2001 Apr; 282(5):1080-4. PubMed ID: 11302724
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages.
Isogai Y; Akatsu T; Ishizuya T; Yamaguchi A; Hori M; Takahashi N; Suda T
J Bone Miner Res; 1996 Oct; 11(10):1384-93. PubMed ID: 8889836
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors.
Scutt A; Bertram P
J Bone Miner Res; 1995 Mar; 10(3):474-87. PubMed ID: 7785470
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
[TBL] [Abstract][Full Text] [Related]
32. The interleukin-6/soluble interleukin-6 receptor system induces parathyroid hormone-related protein in human osteoblastic cells.
Guillén C; de Gortázar AR; Esbrit P
Calcif Tissue Int; 2004 Aug; 75(2):153-9. PubMed ID: 15129368
[TBL] [Abstract][Full Text] [Related]
33. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
34. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
Gitelman SE; Kirk M; Ye JQ; Filvaroff EH; Kahn AJ; Derynck R
Cell Growth Differ; 1995 Jul; 6(7):827-36. PubMed ID: 7547504
[TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
37. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells.
Dean DD; Schwartz Z; Blanchard CR; Liu Y; Agrawal CM; Lohmann CH; Sylvia VL; Boyan BD
J Orthop Res; 1999 Jan; 17(1):9-17. PubMed ID: 10073642
[TBL] [Abstract][Full Text] [Related]
38. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
Udagawa N; Takahashi N; Katagiri T; Tamura T; Wada S; Findlay DM; Martin TJ; Hirota H; Taga T; Kishimoto T; Suda T
J Exp Med; 1995 Nov; 182(5):1461-8. PubMed ID: 7595216
[TBL] [Abstract][Full Text] [Related]
39. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.
Hargreaves PG; Wang F; Antcliff J; Murphy G; Lawry J; Russell RG; Croucher PI
Br J Haematol; 1998 Jun; 101(4):694-702. PubMed ID: 9674743
[TBL] [Abstract][Full Text] [Related]
40. The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts.
Irwin CR; Myrillas TT; Traynor P; Leadbetter N; Cawston TE
J Periodontol; 2002 Jul; 73(7):741-7. PubMed ID: 12146533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
